Common cancers in adolescents

Cancer Treatment Reviews

Volumn 33, Issue 7, 2007, Pages 597-602

  Barr, Ronald D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Adolescents; Cancer

Indexed keywords

ANTINEOPLASTIC AGENT; IODINE; MELANOCORTIN 1 RECEPTOR; MISMATCH REPAIR PROTEIN PMS2; PROTEIN RET;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADJUVANT THERAPY; ADOLESCENT; ADULT; ASTROCYTOMA; BETEL NUT; BREAST CANCER; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CENTRAL NERVOUS SYSTEM TUMOR; CHERNOBYL ACCIDENT; CHILDHOOD CANCER; CIGARETTE SMOKING; COLON CANCER; DEVELOPING COUNTRY; DIGESTIVE SYSTEM CANCER; EPITHELIUM TUMOR; EWING SARCOMA; GLIOMA; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IODINE DEFICIENCY; LARYNX CARCINOMA; LEUKEMIA; LUNG CANCER; LYMPHOMA; MANTLE CELL LYMPHOMA; MOUTH CANCER; MULTIPLE ENDOCRINE NEOPLASIA; NASOPHARYNX CARCINOMA; NEPHROBLASTOMA; NEUROBLASTOMA; ORTHOPEDIC SURGERY; OSTEOSARCOMA; OVARY CARCINOMA; PREVALENCE; PROGNOSIS; REVIEW; SALIVARY GLAND CANCER; SKIN CANCER; SOFT TISSUE CANCER; SOFT TISSUE SARCOMA; TESTIS CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; UROGENITAL TRACT CANCER; UTERINE CERVIX CARCINOMA;

ADOLESCENT; HUMANS; NEOPLASMS; ONTARIO; PREVALENCE; RISK FACTORS;

EID: 35649006740     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2006.11.003     Document Type: Review

References (52)

1. Barr R.D. On cancer control and the adolescent. Med Pediatr Oncol 32 (1999) 404-410
2. Bleyer A, O'Leary M, Barr R, Ries LAG, editors. Cancer epidemiology in older adolescents and young adults 15-29 years of age, including SEER incidence and survival: 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD; 2006.
3. Steliarova-Foucher E., Stiller C., Lacour B., and Kaatsch P. International Classification of Childhood Cancer. Cancer 103 (2005) 1457-1467 3rd ed.
4. In: Fritz A., Percy C., Jack A., et al. (Eds). International classification of diseases for oncology. 3rd ed. (2000), World Health Organization, Geneva
5. Barr R.D., Holowaty E.J., and Birch J.M. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer 106 (2006) 1425-1430
6. Pritchard-Jones K., Kaatsch P., Steliarova-Foucher E., Stiller C.A., and Coeberg J.W. Cancer in children and adolescents in Europe: Developments over 20 years and future challenges. Eur J Cancer 42 (2006) 2183-2190
7. Bleyer A, Albritton A, Siegal S, Phillips M, Barr R. Challenges and opportunities. In: Bleyer WA, Barr RD, editors. Cancer in Adolescents and Young Adults. Heidelberg, Springer; in press.
8. Barr R., Ribeiro R., Agarwal B., Masera G., Hesseling P., and Magrath I. Pediatric oncology in countries with limited resources. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 5th ed. (2006), Lippincott Williams and Wilkins, Philadelphia 1604-1616
9. Barr R.D., and Magrath I.T. Hodgkin's disease in children 4 years of age or younger. Cancer 69 (1992) 601-602
10. MacMahon B. Epidemiological evidence on the nature of Hodgkin's Disease. Cancer 10 (1957) 1045-1054
11. Mueller N.E., and Grufferman S. The epidemiology of Hodgkin's Disease. In: Mauch P.M., Armitage J.O., Diehl V., Hoppe R.T., and Weiss L.M. (Eds). Hodgkin's disease (1999), Lippincott Williams and Wilkins, Philadelphia 61-78
12. Chiu B.C., and Weisenburger D.D. An update on the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma 4 (2003) 161-168
13. Link M.P., and Weinstein H.J. Malignant non-Hodgkin lymphomas in children. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 5th ed. (2006), Lippincott Williams and Wilkins, Philadelphia 722-747
14. Stock W., Sather H., Dodge R.K., et al. Outcome of adolescents and young adults with ALL: a comparison of Children's Cancer Group (CCG) and Cancer and Leukemia Group B (CALGB) regimens. Blood 96 (2000) 467a
15. Boissel N., Auclerc M.F., Lheritier V., et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 21 (2003) 774-780
16. de Bout J.M., van der Holt B., Dekker A.W., et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia (ALL) treated on pediatric versus adult ALL protocols. Blood 102 (2003) 222a
17. Testi A.M., Valsecchi M.G., Conter V., et al. Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols. Blood 104 (2004) 539a
18. Nachman J., Siebel N., Sather H., et al. Outcome for adolescents and younger adults 16-21 years of age (AYA) with acute lymphoblastic leukemia (ALL) treated on the Children's Cancer Group (CCG) 1961 study. Blood 104 (2004) 196a
19. Barry E, De Angelo DJ, Neuberg D et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana Farber Cancer Institute ALL Consortium protocols. J Clin Oncol; in press.
20. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Co-operative Group. Ann Int Med 103 (1985) 626-629
21. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
22. Golub T.R., and Arceci R.J. Acute myelogenous leukemia. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 5th ed. (2006), Lippincott Williams and Wilkins, Philadelphia 591-644
23. Barr R.D., and Kasili E.G. Caring for children with cancer in the developing world. In: Pochedly C. (Ed). Neoplastic diseases of childhood (1994), Harwood Academic Publishers, Chur 1535-1558
24. Cavdar A.O., Arcasoy A., Babacan E., et al. Ocular granulocytic sarcoma (chloromas) with acute myelomonocytic leukemia in Turkish children. Cancer 41 (1978) 1606-1609
25. Smith M.A., Freidlin B., Ries L.A., and Simon R. Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90 (1998) 1269-1277
26. Barr R.D. The challenge of childhood cancer in the developing world. E Afr Med J 71 (1994) 223-226
27. Agha M., DiMonte B., Greenberg M., Greenberg C., Barr R., and McLaughlin J.R. Incidence trends and projections for childhood cancer in Ontario. Int J Cancer 188 (2006) 2809-2815
28. Franks L.M., Bollen A., Seeger R.C., et al. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 79 (1997) 2028-2035
29. Nikiforov Y., and Gnepp D.R. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 74 (1994) 748-766
30. Brandi M.L., Gagel R.F., Angeli A., et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86 (2001) 5658-5671
31. Youl P., Aitken J., Hayward N., et al. Melanoma in adolescents: a case control study of risk factors in Queensland, Australia. Int J Cancer 98 (2002) 92-98
32. Tucker M.A., Fraser M.C., Goldstein A.M., et al. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 94 (2002) 3192-3209
33. Kennedy C., terHuurne J., Berkhout M., et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117 (2001) 294-300
34. Miller A.J., and Mihm M.C. Melanoma. N Engl J Med 255 (2006) 51-65
35. Kuehn B.M. CDC panel backs routine HPV vaccination. JAMA 296 (2006) 640-641
36. Mangan S.A., Legano L.A., Rosen C.M., et al. Increased prevalence of abnormal Papanicolaou smears in urban adolescents. Arch Pediatr Adolesc Med 151 (1997) 481-484
37. Ambros I.M., Ambros P.E., Stoehl S., et al. M1C2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from M1C2 expression and specific chromosome aberration. Cancer 67 (1991) 1886-1893
38. Ladanyi M., Lewis R., Garin-Chesa P., et al. EWS re-arrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and M1C2 expression. Diagn Mol Pathol 2 (1993) 141-146
39. Paulussen M., Ahrens S., Jurgens H.F., et al. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies. Proc ASCO 22 abstr. (2003) 816
40. Pakulis P.J., Young N.L., and Davis A.M. Evaluating physical function in an adolescent bone tumor population. Pediatr Blood Cancer 45 (2005) 635-643
41. Grier H.E. Soft tissue sarcoma: Apples, oranges and passion fruit. J Clin Oncol 17 (1999) 3695-3696
42. Thomas J.O. Acquired immunodeficiency syndrome-associated cancers in sub-Saharan Africa. Semin Oncol 28 (2001) 198-206
43. Chintu C., Athale U.H., and Patil P.S. Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child 73 (1995) 100-104
44. Tomar S.L., Winn D.M., Swango P.A., et al. Oral mucosal smokeless tobacco lesions among adolescents in the United States. J Dent Res 76 (1997) 1277-1286
45. Neel H.B., Pearson G.R., and Taylor W.F. Antibodies to Epstein-Barr virus in patients with naso-pharyngeal carcinoma and in comparison groups. Ann Otol Rhinol Laryngol 93 (1984) 477-482
46. Solomon D., Smith R.R., Kashima H.K., and Leventhal B.G. Malignant transformation in non-irradiated recurrent respiratory papillomatosis. Laryngoscope 95 (1985) 900-904
47. Meloni A.M., Dobbs R.M., Pontes J.E., et al. Translocation (X; 1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet 65 (1993) 1-6
48. Davis C.J., Mostofi F.K., and Sesterhenn I.A. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 19 (1995) 1-11
49. Bhatia S., Robison L.L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334 (1996) 745-751
50. Donaldson S.S., and Hancock S.L. Second cancers after Hodgkin's disease in childhood. N Engl J Med 334 (1996) 792-794
51. Barr R.D., and Greenberg M.L. Cancer surveillance and control in adolescents - similarities and contrasts between Canada and the United States. Pediatr Blood Cancer 46 (2006) 273-277
52. Look A.T., and Aplan P.D. Molecular and genetic basis of childhood cancer. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 5th ed. (2006), Lippincott Williams and Wilkins, Philadelphia 38-85